Poulomi Bhattacharya
Overview
Explore the profile of Poulomi Bhattacharya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sengupta S, Sevigny C, Bhattacharya P, Jordan V, Clarke R
Mol Cancer Res
. 2019 Jan;
17(4):918-928.
PMID: 30655322
Approximately 30% of aromatase-inhibitor-resistant, estrogen receptor-positive patients with breast cancer benefit from treatment with estrogen. This enigmatic estrogen action is not well understood and how it occurs remains elusive. Studies...
2.
Li N, Bhattacharya P, Karavalakis G, Williams K, Gysel N, Rivera-Rios N
Toxicol Rep
. 2017 Oct;
1:802-811.
PMID: 28962293
Commercial charbroiling emissions are a significant source of ambient particulate matter (PM) in urban settings. The objective of this study was to determine whether organic extract of PM emissions from...
3.
Bhattacharya P, Abderrahman B, Jordan V
Expert Rev Anticancer Ther
. 2017 Mar;
17(4):297-310.
PMID: 28281842
Extended adjuvant (5-10 years) therapy targeted to the estrogen receptor (ER) has significantly decreased mortality from breast cancer (BC). Areas covered: Translational research advanced clinical testing of extended adjuvant therapy...
4.
Bhattacharya P, Abderrahman B, Jordan V
J Clin Oncol
. 2017 Jan;
35(3):379.
PMID: 28095275
No abstract available.
5.
Jordan V, Fan P, Abderrahman B, Maximov P, Hawsawi Y, Bhattacharya P, et al.
Discov Med
. 2016 Jun;
21(117):411-27.
PMID: 27355337
The combined incidence and the extended disease course of breast and prostate cancer is a major challenge for health care systems. The solution for society requires an economically viable treatment...
6.
Ganesan S, Bhattacharya P, Keating A
Toxicol Appl Pharmacol
. 2013 Aug;
272(3):690-6.
PMID: 23969067
7,12-Dimethylbenz[a]anthracene (DMBA) destroys ovarian follicles at all stages of development. This study investigated DMBA-induced DNA double strand break (DSB) formation with subsequent activation of the ovarian DNA repair response in...
7.
Bhattacharya P, Madden J, Sen N, Hoyer P, Keating A
Toxicol Appl Pharmacol
. 2013 Jan;
267(1):49-56.
PMID: 23274565
4-Vinylcyclohexene diepoxide (VCD) destroys ovarian primordial and small primary follicles via apoptosis. In mice, VCD exposure induces ovarian mRNA expression of glutathione S-transferase (GST) family members, including isoform mu (Gstm)....
8.
Yan Y, Bhattacharya P, He X, Ponugoti B, Marquardt B, Layman J, et al.
J Endocrinol
. 2012 Jul;
214(3):421-35.
PMID: 22761277
In mammals, parathyroid hormone-related peptide (PTHrP, alias PTH-like hormone (Pthlh)) acts as a paracrine hormone that regulates the patterning of cartilage, bone, teeth, pancreas, and thymus. Beyond mammals, however, little...
9.
Bhattacharya P, Keating A
Toxicol Appl Pharmacol
. 2012 Apr;
261(3):227-35.
PMID: 22531813
The mammalian ovary is a heterogeneous organ and contains oocyte-containing follicles at varying stages of development. The most immature follicular stage, the primordial follicle, comprises the ovarian reserve and is...
10.
Bhattacharya P, Keating A
Toxicol Appl Pharmacol
. 2012 Mar;
260(2):201-8.
PMID: 22406437
7,12-Dimethylbenz[a]anthracene (DMBA) destroys ovarian follicles at all developmental stages. This study investigated a role for the glutathione S-transferase (Gst) isoforms alpha (a), mu (m) and pi (p) and the transcription...